{"database": "openregs", "table": "documents", "rows": [["FDA-2021-N-0002-0009", "FDA", "FDA-2021-N-0002", "FOI Summary oA 200-684 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2021-10-22T04:00:00Z", 2021, 10, null, null, "2021-10-26T14:36:52Z", null, 0, 0, "0900006484de3d1a"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-N-0002-0009"], "units": {}, "query_ms": 62.6525140251033, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}